News | April 30, 2025
ekincare raises investment from MSD IDEA Studio Asia Pacific
ekincare has raised a total funding of $22M since 2015 till date
ekincare has raised a total funding of $22M since 2015 till date
The inspection concluded with 6 observations and none of them were related to Data Integrity
The positive opinions are based on applications submitted by Biosimilar Collaborations Ireland Limited
Distribution agreement enables FUJIFILM India to offer Spectra Logic advanced tape libraries and software solutions to enterprise customers and channel partners
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
Subscribe To Our Newsletter & Stay Updated
